pharmaglobenews

pharmaglobenews

Postpartum Depression Pipeline 2026: Key Drug Candidates, Clinical Trials, and Market Insights

DelveInsight’s “Postpartum Depression Pipeline Analysis 2026” delivers detailed perspectives on 10+ organizations and 10+ pipeline therapeutics within the Postpartum Depression pipeline arena. The analysis encompasses Postpartum Depression pipeline therapeutic profiles, incorporating clinical and nonclinical phase candidates. It additionally features Postpartum Depression pipeline
22 July 2026

Parkinson’s Disease Levodopa-Induced Dyskinesia Market Set to Witness Significant Growth Driven by Rising Prevalence, Pipeline Advancements, and Expanding Therapeutic Options Through 2034

Parkinson’s Disease Levodopa-Induced Dyskinesia Market Summary As people age, the occurrence of Parkinson’s disease tends to rise, particularly among the elderly demographic, and given the prolonged duration of the disease in affected individuals, the probability of developing Levodopa-induced Dyskinesia (LID) over time
21 July 2026

Spinocerebellar Ataxias Pipeline Gains Momentum with 10+ Emerging Therapies Across Clinical Development, Driven by Advances in Gene-Silencing and Regenerative Medicine

The Spinocerebellar Ataxias pipeline landscape is witnessing significant progress, fueled by increasing research into gene-targeted therapies, antisense oligonucleotides, stem cell-based approaches, and disease-modifying treatment strategies. Growing scientific understanding of the genetic mechanisms underlying Spinocerebellar Ataxias is encouraging the development of innovative therapeutic
21 July 2026

Healthcare Analytics Market Market Insights, Trends and Forecast 2034

DelveInsight’s “Healthcare Analytics Market, Trends, Analysis and Forecast – 2034” report delivers an in-depth understanding of the Healthcare Analytics market, historical and forecasted market size, key drivers, challenges, competitive landscape, and regional dynamics across North America, Europe, Asia-Pacific, and the Rest of
20 July 2026

The Global Herbal Medicine Market was valued at USD 71,445.63 million in 2024, growing at a CAGR of 10.18% to reach USD 154,072.10 million by 2032, estimates DelveInsight

DelveInsight’s Herbal Medicine Market report delivers a comprehensive analysis of the market by Category (Herbal Pharmaceuticals, Herbal Functional Food, Herbal Beauty Products, and Herbal Dietary Supplements), by Source (Leaves, Roots and Barks, Fruits, Whole Plants, and Others), by Form (Capsules and Tablets,
16 July 2026
1 6 7 8 9 10 38